Poly(adenosine diphosphate-ribose) polymerase expression in serous ovarian carcinoma: Correlation with p53, MIB-1, and outcome

International Journal of Gynecological Pathology

Volumn 26, Issue 2, 2007, Pages 147-153

  Brustmann, Hermann ^a  

^a Thermenklinikum ^*  (Austria)

Author keywords

Apoptosis; Grading; Outcome; Ovarian carcinoma; p53; Poly(adenosine diphosphate ribose) polymerase; Proliferation

Indexed keywords

BIOLOGICAL MARKER; FORMALDEHYDE; KI 67 ANTIGEN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PARAFFIN; PROTEIN P53;

ADULT; AGED; ANALYTICAL PARAMETERS; ARTICLE; CELL NUCLEUS; CELL PROLIFERATION; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CYSTADENOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LOG RANK TEST; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SEROSA; TUMOR CELL; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; CELL PROLIFERATION; CYSTADENOMA, SEROUS; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KI-67 ANTIGEN; MIDDLE AGED; OVARIAN NEOPLASMS; POLY(ADP-RIBOSE) POLYMERASES; PROGNOSIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 34147121608     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pgp.0000235064.93182.ec     Document Type: Article

References (27)

1. Prat J. Pathology of the Ovary. Philadelphia, PA: Saunders, 2004.
2. Beneke R, Geisen C, Zevnik B, et al. DNA excision repair and DNA damage-induced apoptosis are linked to poly(ADP-ribosyl)-ation but have different requirements for p53. Mol Cell Biol 2000;20:6695-703.
3. Wieler S, Gagne JP, Vaziri H, et al. Poly(ADP-ribose) polymerase 1 is a positive regulator of the p53-mediated G1 arrest response following ionizing radiation. J Biol Chem 2003;278:18914-21.
4. Khalifeh I, Munkarah AR, Lonardo F, et al. Expression of Cox-2, CD34, Bcl-2, and p53 and survival in patients with primary peritoneal serous carcinoma and primary ovarian serous carcinoma. Int J Gynecol Pathol 2004;23:162-9.
5. Garzetti GG, Ciavattini A, Goteri G, et al. Ki67 antigen immunostaining (MIB 1 monoclonal antibody) in serous ovarian tumors: index of proliferative activity with prognostic significance. Gynecol Oncol 1995;56:169-74.
6. Bell DA, Longacre TA, Prat J, et al. Serous borderline (low malignant potential, atypical proliferative) ovarian tumors: workshop perspectives. Hum Pathol 2004;35:934-48.
7. Scully RE, Young RH, Clement PB. Tumors of the Ovary, Maldeveloped Gonads, Fallopian Tube and Broad Ligament. Atlas of Tumor Pathology. Washington DC: Armed Forces Institute of Pathology, 1996:37.
8. Shimizu Y, Kamoi S, Amada S, et al. Toward the development of an universal grading system for ovarian epithelial carcinoma. Cancer 1998;82:893-901.
9. Malpica A, Deavers MT, Lu K, et al. Grading ovarian serous carcinoma using a two-tier system. Am J Surg Pathol 2004;28:496-504.
10. Brustmann H. Expression of cellular apoptosis susceptibility protein in serous ovarian carcinoma: a clinicopathologic and immunohistochemical study. Gynecol Oncol 2004;92:268-76.
11. Peiro G, Diebold J, Baretton GB, et al. Cellular apoptosis susceptibility gene expression in endometrial carcinoma: correlation with bcl-2, bax, and caspase-3 expression and outcome. Int J Gynecol Pathol 2001;20:359-67.
12. Holmes WF, Soprano DR, Soprano KJ. Synthetic retinoids as inducers of apoptosis in ovarian carcinoma cell lines. J Cell Physiol 2004;199:317-29.
13. McMenamin ME, ONeill AJ, Gaffney EF. Extent of apoptosis in ovarian serous carcinoma: relation to mitotic and proliferative indices, p53 expression, and survival. J Clin Pathol 1997;50:242-6.
14. Nomura F, Yaguchi M, Togawa A, et al. Enhancement of polyadenosine diphosphate-ribosylation in human hepatocellular carcinoma. J Gastroenterol Hepatol 2000;15:529-35.
15. Shimizu S, Nomura F, Tomonaga T, et al. Expression of poly(ADP-ribose) polymerase in human hepatocellular carcinoma and analysis of biopsy specimens obtained under sonographic guidance. Oncol Rep 2004;12:821-5.
16. Staibano S, Pepe S, LoMuzio L, et al. Poly(adenosine diphosphate-ribose) polymerase 1 expression in malignant melanomas from photoexposed areas of the head and neck region. Hum Pathol 2005;36:724-31.
17. Tong WM, Cortes U, Wang ZQ. Poly(ADP-ribose) polymerase: a guardian angel protecting the genome and suppressing tumorigenesis. Biochim Biophys Acta 2001;1552:27-37.
18. Masutani M, Nakagama H, Sugimura T. Poly(ADP-ribosyl)ation in relation to cancer and autoimmune disease. Cell Mol Life Sci 2005;62:769-83.
19. Wang X, Ohnishi K, Takahashi A, et al. Poly(ADP-ribosyl)ation is required for p53-dependent signal transduction induced by radiation. Oncogene 1998;17:2819-25.
20. Bernstein C, Bernstein H, Payne CM, et al. DNA repair/proapoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis. Mutat Res 2002;511:145-78.
21. D'Amours D, Germain M, Orth K, et al. Proteolysis of poly(ADP-ribose) polymerase by caspase-3: kinetics of cleavage of mono(ADP-ribosyl) ated and DNA-bound substrates. Radiat Res 1998;150:3-10.
22. Simbulan-Rosenthal CM, Rosenthal DS, Iyer S, et al. Transient poly(ADP-ribosyl)ation of nuclear proteins and role of poly(ADP-ribose) polymerase in the early stages of apoptosis. J Biol Chem 1998;273:13703-12.
23. Simbulan-Rosenthal CM, Rosenthal DS, Luo R, et al. Poly(ADP-ribosyl) ation of p53 during apoptosis in human osteosarcoma cells. Cancer Res 1999;59:2190-4.
24. Baisch H. Elevated Ki-67 expression is correlated with TNFα- and IFNγ-induced apoptosis in tumor cells. Cell Prolif 2002;35:333-42.
25. Helmbach H, Kern MA, Rossmann E, et al. Drug resistance towards etoposide and cisplatin in human melanoma cells is associated with drug-dependent apoptosis deficiency. J Invest Dermatol 2002;118:923-32.
26. Tentori I, Graziani G. Chemopotentiation by PARP inhibitors in cancer therapy. Pharmacol Res 2005;52:25-33.
27. Munoz-Gamez JA, Martin-Oliva D, Aguilar-Quesada R, et al. PARP inhibition sensitizes p53-deficient breast cancer cells to doxorubicin-induced apoptosis. Biochem J 2005;386:119-25.